Hong Seng to acquire 51% in RZAC

PETALING JAYA: Hong Seng Consolidated Bhd’s wholly-owned subsidiary, HS Bio Sdn Bhd, has signed a heads of agreement following a proposed acquisition of 51% shareholdings in RZAC Immunesafe Sdn Bhd for RM40.3mil.

In a filing with Bursa Malaysia yesterday, the company said the agreement was signed with Datuk Seri Shahril Mokhtar, Datuk Wan Khalik Wan Muhammad and RZAC Business Sdn Bhd. – Bernama

Article type: free
User access status:
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Next In Business News

Going gets tough for Malaysia ahead of 2023
Asia’s inflation still moderate
Steady residential sector
Bermaz rides on buoyant car sales
Headline inflation for August hits 4.7% year-on-year
Steel makers fear deepening crisis
Prospects for Covid-19 vaccine companies diminish
Short position: Glove makers, MREITs
No intervention likely to actively boost ringgit
Islamic fintech growing fast in the country

Others Also Read